|
UHRF1BP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.640200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.896100E-02 |
| Normal-vs-Stage2 |
6.863600E-01 |
| Normal-vs-Stage3 |
1.454210E-02 |
| Normal-vs-Stage4 |
4.202100E-03 |
| Stage1-vs-Stage2 |
4.663500E-02 |
| Stage1-vs-Stage3 |
2.536400E-01 |
| Stage1-vs-Stage4 |
1.382820E-01 |
| Stage2-vs-Stage3 |
2.266200E-02 |
| Stage2-vs-Stage4 |
9.803900E-03 |
| Stage3-vs-Stage4 |
5.535800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.554300E-02 |
| Normal-vs-AfricanAmerican |
3.016400E-01 |
| Normal-vs-Asian |
3.354200E-02 |
| Caucasian-vs-AfricanAmerican |
7.465800E-01 |
| Caucasian-vs-Asian |
5.117600E-01 |
| AfricanAmerican-vs-Asian |
4.623400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.101780E-01 |
| Normal-vs-Female |
6.534400E-02 |
| Male-vs-Female |
9.042200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.705620E-01 |
| Normal-vs-Age(41-60Yrs) |
2.742400E-02 |
| Normal-vs-Age(61-80Yrs) |
6.875700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.283770E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.289000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.410600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.464000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.607800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.640200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.340600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.418200E-01 |
| Classical-VS-Follicular |
5.755800E-01 |
| Classical-VS-Other |
1.626980E-01 |
| Classical-VS-Normal |
1.642020E-01 |
| Tall-VS-Follicular |
6.955800E-01 |
| Tall-VS-Other |
2.433000E-01 |
| Tall-VS-Normal |
6.481700E-02 |
| Follicular-VS-Other |
2.985200E-01 |
| Follicular-VS-Normal |
1.055840E-01 |
| Other-VS-Normal |
2.993800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.700400E-02 |
| Normal-vs-N1 |
1.848070E-02 |
| N0-vs-N1 |
2.565000E-01 |
|
|
